These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 15593201

  • 1. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Kobayashi M, Yasui N, Ishimaru N, Arakaki R, Hayashi Y.
    Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
    [Abstract] [Full Text] [Related]

  • 2. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
    Arakaki R, Ishimaru N, Saito I, Kobayashi M, Yasui N, Sumida T, Hayashi Y.
    Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
    [Abstract] [Full Text] [Related]

  • 3. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kalden JR, Lakomek HJ, Schmidt RE.
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [Abstract] [Full Text] [Related]

  • 4. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y, Arakaki R, Ishimaru N.
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [Abstract] [Full Text] [Related]

  • 5. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.
    Ishimaru N, Yoneda T, Saegusa K, Yanagi K, Haneji N, Moriyama K, Saito I, Hayashi Y.
    Am J Pathol; 2000 May; 156(5):1557-64. PubMed ID: 10793067
    [Abstract] [Full Text] [Related]

  • 6. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
    Ishimaru N, Yanagi K, Ogawa K, Suda T, Saito I, Hayashi Y.
    J Immunol; 2001 Nov 15; 167(10):6031-7. PubMed ID: 11698484
    [Abstract] [Full Text] [Related]

  • 7. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N, Hamano H, Yanagi K, Hayashi Y.
    J Immunol; 1994 Sep 15; 153(6):2769-77. PubMed ID: 8077681
    [Abstract] [Full Text] [Related]

  • 8. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
    Hayashi Y, Ishimaru N, Arakaki R, Tsukumo S, Fukui H, Kishihara K, Shiota H, Yasutomo K, Hayashi Y.
    Arthritis Rheum; 2004 Sep 15; 50(9):2903-10. PubMed ID: 15457459
    [Abstract] [Full Text] [Related]

  • 9. [Establishment of Sjögren's syndrome models by immunization with alpha-Fodrin: experiment with mice].
    He J, Wang H, Zhao JX, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 26; 88(33):2360-3. PubMed ID: 19087701
    [Abstract] [Full Text] [Related]

  • 10. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
    Zeher M, Szodoray P, Gyimesi E, Szondy Z.
    Arthritis Rheum; 1999 Aug 26; 42(8):1673-81. PubMed ID: 10446867
    [Abstract] [Full Text] [Related]

  • 11. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
    Wang Y, Virji AS, Howard P, Sayani Y, Zhang J, Achu P, McArthur C.
    Arch Oral Biol; 2006 Jul 26; 51(7):558-66. PubMed ID: 16405863
    [Abstract] [Full Text] [Related]

  • 12. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
    Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y.
    Am J Pathol; 2005 Oct 26; 167(4):1051-9. PubMed ID: 16192640
    [Abstract] [Full Text] [Related]

  • 13. T cell reactivity to Sjögren's syndrome related antigen La(SSB).
    Helsloot J, Sturgess A.
    J Rheumatol; 1997 Dec 26; 24(12):2340-7. PubMed ID: 9415639
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
    Yavuz S, Toker E, Bicakcigil M, Mumcu G, Cakir S.
    J Rheumatol; 2006 Jul 26; 33(7):1289-92. PubMed ID: 16821267
    [Abstract] [Full Text] [Related]

  • 15. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y, Chen LL, Tepavcevic V, Ferdman D, Hodges RR, Dartt DA.
    Exp Eye Res; 2007 Mar 26; 84(3):500-12. PubMed ID: 17208228
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
    Maeno N, Takei S, Imanaka H, Oda H, Yanagi K, Hayashi Y, Miyata K.
    J Rheumatol; 2001 Apr 26; 28(4):860-4. PubMed ID: 11327263
    [Abstract] [Full Text] [Related]

  • 18. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
    Hayashi Y, Yayagi K, Haneji N.
    Arch Immunol Ther Exp (Warsz); 2000 Apr 26; 48(5):399-403. PubMed ID: 11140467
    [Abstract] [Full Text] [Related]

  • 19. [Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity].
    He J, Zhao JX, Wang H, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Mar 04; 88(9):625-9. PubMed ID: 18646720
    [Abstract] [Full Text] [Related]

  • 20. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM.
    Clin Immunol; 2007 Jan 04; 122(1):75-84. PubMed ID: 17045846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.